Cargando…

SARS-CoV-2 in inflammatory bowel disease population: Antibodies, disease and correlation with therapy

BACKGROUND: Guidelines recommend to cease inflammatory bowel disease (IBD) biologic therapy during coronavirus disease 2019 (COVID-19). AIM: To investigate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody positivity in an IBD cohort, COVID-19 disease severity and to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conti, Clara Benedetta, Mainardi, Elsa, Soro, Sara, Testa, Sophie, De Silvestri, Annalisa, Drago, Andrea, Cereatti, Fabrizio, Grassia, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984534/ https://www.ncbi.nlm.nih.gov/pubmed/35432745 http://dx.doi.org/10.4253/wjge.v14.i3.153

Ejemplares similares

AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY
por: Conti, C.B., et al.
Publicado: (2021)

Lights and shadows of SARS-CoV-2 infection risk assessment in endoscopy
por: Grassia, Roberto, et al.
Publicado: (2020)

Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders
por: Mazza, Stefano, et al.
Publicado: (2021)

Endoscopic ultrasound diagnostic gain over computed tomography and magnetic resonance cholangiopancreatography in defining etiology of idiopathic acute pancreatitis
por: Mazza, Stefano, et al.
Publicado: (2022)

Focal Autoimmune Pancreatitis: A Simple Flow Chart for a Challenging Diagnosis
por: Conti, Clara Benedetta, et al.
Publicado: (2020)

Endoscopic management of gastrointestinal leaks and fistulae: What option do we have?
por: Cereatti, Fabrizio, et al.
Publicado: (2020)

EUS-guided fiducial placement for intramural GI neoplasia: a facilitated technique
por: Roberto, Grassia, et al.
Publicado: (2021)

Endoscopic ultrasound-guided sampling of solid pancreatic masses: the fine needle aspiration or fine needle biopsy dilemma. Is the best needle yet to come?
por: Conti, Clara Benedetta, et al.
Publicado: (2019)

Gastric per-oral endoscopic myotomy: Indications, technique, results and comparison with surgical approach
por: Verga, Maria Chiara, et al.
Publicado: (2022)

SARS-CoV-2 and gastrointestinal tract: The dark side of the pandemic
por: Grassia, Roberto, et al.
Publicado: (2020)

Fecal Incontinence in Inflammatory Bowel Disease
por: Kamal, Natasha, et al.
Publicado: (2021)

Disposable Duodenoscopes: Evidence and Open Issues
por: Conti, Clara Benedetta, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

The Copper/Zinc Ratio Correlates With Markers of Disease Activity in Patients With Inflammatory Bowel Disease
por: Schneider, Tobias, et al.
Publicado: (2020)

Association Between Inflammatory Bowel Disease and Pruritus
por: Iwamoto, Shiho, et al.
Publicado: (2020)

Opioid Use in Patients With Inflammatory Bowel Disease
por: Lin, Xiwu, et al.
Publicado: (2020)

Economic Burden of Fatigue in Inflammatory Bowel Disease
por: Ananthakrishnan, Ashwin N, et al.
Publicado: (2023)

HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018)

Disease impact on the quality of life of children with inflammatory bowel disease
por: Chouliaras, Giorgos, et al.
Publicado: (2017)

Fatigue in patients with inflammatory bowel disease in Eastern China
por: Gong, Shan-Shan, et al.
Publicado: (2021)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Hospitalizations and in-hospital mortality for inflammatory bowel disease in Brazil
por: Guedes, Ana Luiza Vilar, et al.
Publicado: (2022)

Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease
por: Wiles, C Alex, et al.
Publicado: (2021)

Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10(−/−) Mice
por: Mannion, Anthony, et al.
Publicado: (2020)

Identification of Risk Factors for Coexisting Sinusitis and Inflammatory Bowel Disease
por: Rai, Victoria, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease Clinic On-site Vaccination Services
por: Hussain, Nadeen, et al.
Publicado: (2021)

Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand
por: Aluzaite, Kristina, et al.
Publicado: (2021)

Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?
por: Conti, Clara Benedetta, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort
por: Lee, Way Seah, et al.
Publicado: (2016)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients
por: Frigstad, Svein Oskar, et al.
Publicado: (2018)

Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery
por: Lee, Dong-won, et al.
Publicado: (2017)

Transitions of care across hospital settings in patients with inflammatory bowel disease
por: Warren, Leigh R, et al.
Publicado: (2019)

Inactive matrix Gla protein is elevated in patients with inflammatory bowel disease
por: Brnic, Darko, et al.
Publicado: (2020)

Characteristics of Fecal Microbiota Transplantation Use in Inflammatory Bowel Disease Cohort
por: Bauer, Christina M, et al.
Publicado: (2020)

Vaccination Rates and Family Barriers Among Children with Inflammatory Bowel Disease
por: Holland, Kathleen J, et al.
Publicado: (2020)

Assessment of Benefit of Advanced Inflammatory Bowel Disease Training: Challenges and Solutions
por: Cushing, Kelly C, et al.
Publicado: (2020)

Nailfold Capillaroscopy as a Biomarker in the Evaluation of Pediatric Inflammatory Bowel Disease
por: Kurowski, Jacob A, et al.
Publicado: (2021)

Risk of Uveitis in Patients With Inflammatory Bowel Disease on Immunosuppressive Drug Therapy
por: Barberio, Julie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_frqd06d3vqapb3tsa74r7tb32b